Interojo Inc. (KOSDAQ:119610)
South Korea · Delayed Price · Currency is KRW 17,900
-490 (-2.66%)
At close: Feb 27, 2026
Interojo Market Cap
Interojo has a market cap or net worth of 204.31 billion as of February 27, 2026. Its market cap has decreased by -48.32% in one year.
Market Cap
204.31B
Enterprise Value
233.27B
Revenue
109.28B
Ranking
n/a
PE Ratio
69.99
Stock Price
17,900.00
Market Cap Chart
Since July 28, 2010, Interojo's market cap has increased from 44.29B to 204.31B, an increase of 361.30%. That is a compound annual growth rate of 10.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 204.31B | 11.81% |
| Dec 30, 2025 | 182.73B | -53.77% |
| Dec 28, 2023 | 395.31B | 11.81% |
| Dec 29, 2022 | 353.55B | -0.83% |
| Dec 30, 2021 | 356.49B | 45.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.75T |
| Celltrion | 52.97T |
| ALTEOGEN | 21.55T |
| Sam Chun Dang Pharm. | 17.61T |
| Vaxcell-Bio Therapeutics | 215.83B |
| JW Lifescience | 211.98B |
| AptaBio Therapeutics | 211.82B |
| REYON Pharmaceutical | 208.54B |